Interactions between vascular endothelium and low density lipoprotein (LDL) have been implicated in the development of atherosclerosis. The effect of normal and oxidized LDL (Ox-LDL) on prostaglandin release by cultured adult human saphenous vein endothelial cells was investigated. Ox-LDL induced a rapid release of prostacyclin (PGI 2 ) to levels which were several-fold higher than those observed with control LDL. PGI 2 release was concentration-dependent and was biphasic, with a first peak occurring within 30 minutes (followed by a decrease), and a second peak occurring after several hours of incubation. PGI 2 production was inhibited by lipoproteindepleted serum and by indomethacin, an antagonist of cyclooxygenase activity. These cells produced mainly PGF^, with some PGE 2 and PGI 2 when stimulated by the ionophore A23187 at confluency. However, among these prostanoids, mainly PGI 2 was produced in response to Ox-LDL. The data indicate that Ox-LDL induces the production of PGI 2 by human vascular endothelial cells. Since Ox-LDL is cytotoxic, this phenomenon may be a manifestation of an early response to injury. (Arteriosclerosis 8:810-818, November/December 1988) T he interaction of low density lipoprotein (LDL) with endothelial cells is of significant interest to researchers in the field of atherosclerosis. LDL is toxic to endothelial cells cultured in serum-free medium.
T he interaction of low density lipoprotein (LDL) with endothelial cells is of significant interest to researchers in the field of atherosclerosis. LDL is toxic to endothelial cells cultured in serum-free medium.
1 -2 LDL cytotoxicity is due to oxidation of its lipid moiety, and oxidized LDL (Ox-LDL) cytotoxicity is prevented by the use of antioxidants in vitro. 3 -6 Endothelial cells, smooth muscle cells,' and leukocytes oxidize LDL in vitro in a manner similar to the oxidation catalyzed by transition metals. 5789 Ox-LDL inhibits macrophage mobility, is metabolized via the scavenger receptor, and induces cholesterol ester accumulation in the macrophage. 9 - 12 Ox-LDL may thus promote atherosclerosis. 3 " 12 Prostacyclin (PGI 2 ) is a potent vasodilator and decreases platelet aggregation. 13 PGI 2 is produced by endothelial cells, and increased levels of 2,3-dinor-6-keto-PGF 1(I , a major urinary metabolite of PGI 2 , have been observed in patients with atherosclerosis. 141516 When endothelial cells are subjected to various forms of injury such as balloon catheter trauma, radiation, shear stress, or exposure to mellitin, PGI 2 is released. 17 -20 We tested the hypothesis that adult human vascular endothelial cells produce PGI 2 in response to Ox-LDL. The data presented support this hypothesis.
) in Morgan's M-199 medium containing 25 mM HEPES, and supplemented with 5% fetal bovine serum (FBS), 50 /Ag/ml bovine endothelial cell growth factor, 100 /Ag/ml porcine heparin, 100 ^g/ml streptomycin, and 100 units/ml penicillin at 37°C in a humid atmosphere containing 5% CO 2 . All experiments with HSVEC were performed with cultures at passages 2 to 4, 3 to 4 weeks after isolation. Under these culture conditions, monolayers have several characteristics of vascular endothelium, such as typical morphology, expression of von Willebrand factor mRNA and protein, as well as production of glycoconjugates specific for the binding of Ulex europaeus I lectin. Human monocytes were isolated by Ficoll hypaque centrifugation followed by adherence to plastic Petri dishes covered with FBS. 22 Monocytes obtained were more than 95% pure as indicated by esterase staining. containing tubes, plasma was separated at 4°C by centrifugation at 1000 g for 20 minutes. Chloramphenicol was then added to a final concentration of 0.005%. Aliquots used for the isolation of control LDL were supplemented with 20 /iM butylated hydroxytoluene (BHT). LDL was isolated, washed, and concentrated by sequential isopycnic ultracentrifugation in the density region 1.025 to 1.055 g/ml. Control LDL was dialyzed with four changes (2 hours each) against 100 volumes of phosphate buffer (PB) consisting of 1.5 mM NaH 2 PCV3.5 mM Na 2 HPO 4 (pH 7.5) supplemented with 1 mM EDTA and 20 /AM BHT. Oxidized LDL was obtained after dialyses with three changes (2 hours each) and a fourth dialysis up to 24 to 48 hours against PB supplemented with 10 nM cupric acetate. After filter sterilization (0.22 /xm, Millex-GV, Millipore Corporation, Bedford, MA), protein concentration was determined by the method of Lowry as modified by Markwell et al. 25 with bovine serum albumin fraction V (Abbot Laboratories, South Pasadena, CA) as a standard. The protein purity of isolated LDL was examined by gradient (4% to 23%) sodium-dodecyl-sulfate polyacrylamide gel electrophoresis and only apolipoprotein (apo) B-100 was noted in control LDL. Before each medium reconstitution, agarose electrophoresis was used to check control LDL for typical ^-mobility and Ox-LDL for increased anodic mobility as reported by others.
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Measure of EDTA Cytotoxicity
Cytotoxicity of EDTA in serum-free Dulbecco's modified Eagle medium (DMEM) was assessed by measuring the specific release of 111 ln after 111 ln-oxine labeling of HSVEC monolayers. Metabolic labeling of the cells was performed as described by Pober et al. 27 Confluent HSVEC were washed with Hank's balanced salt solution (HBSS) and incubated with 4 /xCi/ml " 1 ln-oxine. After 30 minutes, the monolayers were washed with Tyrode's balanced salt solution supplemented with 4% bovine albumin; the cells were then incubated in Tyrode-albumin solution at 37°C. After 90 minutes, the period of time necessary for spontaneous 1l1 ln release to reach a constant level (2% per 24 hours), the monolayers were washed with HBSS and incubated with DMEM containing EDTA (pH 7.5). After 24 hours, specific release was measured as the difference of EDTA-induced and spontaneously released y radioactivity, normalized to the difference of total releasable and spontaneously released radioactivity. The total releasable 111 ln was assessed by measuring radioactivity in the medium after treatment of the cells with 2% Nonidet P-40.
Quantitation of Lipid Oxidation
Oxidation of LDL lipids was estimated by assaying for thiobarbituric acid reactive substances (TBARS) by using a modification of the fluorometric method of Yagi. 28 Briefly, 50 /ug of LDL protein (0.5 mg/ml) was precipitated with 1 ml of 20% trichloroacetic acid containing 0.1% BHT; 1 ml of a freshly dissolved solution (0.67%) of thiobarbituric acid was added and the mixture was boiled for 45 minutes, cooled with running water, and cleared by centrifugation. Fluorometric measurements were made at 553 nm with 515 nm excitation. The amount of malondialdehyde (MDA) equivalent was determined against a standard curve obtained using freshly diluted 1,1,3,3-tetramethoxypropane. The degree of LDL oxidation was expressed in nanomoles of MDA equivalent per milligram of LDL protein. Under these conditions, the TBARS values for control LDL preparations were typically 0 to 0.2 nmol/mg, while the values for Ox-LDL preparations were 3 to 18 nmol/mg, depending on the length of the fourth dialysis. Highly oxidized LDL (TBARS above 18 nmol/mg) was degraded, as evidenced by a trail of lipid staining (fat red 7B) after agarose electrophoresis. In our experiments, the maximum level of oxidation in Ox-LDL used had a TBARS value of 16 nmol/mg.
Incubation of Low Density Lipoprotein with Cells
To prevent oxidation of control LDL, incubation media were combined with concentrated DMEM just before incubation. Such preparations were found to have a level of gram-negative bacterial endotoxin below 20 pg/ml with the chromogenic limulus amebocyte lysate assay (MA Bioproducts, Walkersville, MD). Concentrations of nonlipoprotein species (including BHT, EDTA, and Cu 2+ ) were identical in both control LDL and Ox-LDL preparations.
HSVEC were grown on 2 cm 2 wells until confluency (defined as the absence of open space on the monolayer), were washed twice in HBSS, and were incubated once in 300 ju.l of medium. Before experimental incubation, each well was examined by inverted phase contrast microscopy, and any discontinuity in the monolayer resulted in the elimination of the well from the experiment. Human monocytes (3xio 4 ) were incubated in 0.32 cm 2 wells containing 250 /il of LDL preparation. In each experiment, control LDL and Ox-LDL isolated from the same lipoprotein donor were used on the cells obtained from another single donor.
Measurements of Prostaglandin Production
Radioimmunoassay
Prostaglandin production was measured by radioimmunoassay (RIA) of 6-keto-PGF 1a (a stable PGI 2 metabolite) or PGE 2 in the medium. 29 After each incubation, 200 /xl of medium collected from HSVEC monolayers or from the centrifuged monocyte suspensions were frozen at -80°C until analysis. Rabbit antiserum specific for 6-keto-PGF 1o or PGE 2 was pre-precipitated overnight at 4°C with sheep anti-IgG in the presence of nonimmune rabbit serum and PBS-EDTA. Serial dilutions of unlabeled prostaglandin standard were then incubated overnight at 4°C with tritiated standard and the antibodies. After decantation, the radioactivity was measured by liquid scintillation spectrometry, and quenching was monitored using an external source of 137 Cs. The sensitivity of the assay was 20 pg and a 50% displacement was obtained at about 300 pg. The specificities of our antisera have been previously reported; 30 however, Ox-LDL did react with the antisera (see Results) and therefore, in all experiments, background values (obtained from RIA on parallel incubations of media in the absence of cells) were subtracted from total values.
High Performance Liquid Chromatographic Analysis
Further characterization of PGI 2 production was made by reversed-phase high performance liquid chromatography (RP-HPLC) analysis of the medium after 3 H-ara- Values are the means±SD of triplicate determinations on duplicate incubations. Control low density lipoproteins (200 /i,g/ml) were incubated with or without human saphenous vein endothelial cells in either Eagle's minimum essential medium (MEM) or Dulbecco's modified Eagle's medium (DMEM) containing 1.7 or 20 /u.M butylated hydroxytoluene (BHT). After 24 hours, the degree of oxidation (TBARS) in the media was measured as described in the Methods section.
chidonic acid metabolic labeling. Tritiated arachidonic acid (240 Ci/mmol, New England Nuclear, Boston, MA) was adsorbed to polypropylene under a stream of purified N 2 and was transferred to FBS by a 45-minute incubation at 37°C. After washes with HBSS, subconfluent monolayers were incubated with 10 jtCi/ml of 3 H-arachidonic acid in fully supplemented M-199 medium. After 48 hours, approximately 80% of the radioactivity was associated with the cells; the monolayers were washed in HBSSalbumin (4%) and then HBSS and were incubated with the lipoprotein or the ionophore A23187. After incubation, the entire medium was collected and acidified. The prostanoids were adsorbed onto a octadecylsilyl silica (C18) cartridge (Sep-pak, Millipore Corporation), were washed with a mixture of ethanol and water (15:85) and then with ether and were eluted with methyl formate, as described by Powell. 31 Extraction efficiencies were greater than 95% in all cases. The solvent was evaporated under N 2 , and the residue was redissolved in ethanol. The prostanoids were fractionated by RP-HPLC in a 4.6 m m x i 5 cm C18 column (3 /Aim, Adsorbosphere, Alltech Association, Incorporated, Deerfield, MA) guarded with a C18 precolumn (Brownlee Labs Incorporated, Santa Clara, MA). The mobile phase was Terragno's biphasic solvent (17.3 mM H3PO4/CH3CN, 7:3) used at a flow rate of 1.7 ml/min.32 Aliquots (1 ml) were collected and radioactivity was measured. Identification of the elution peaks was based on retention volume of authentic tritiated standards (6-keto-PGF lo , PGF 2a , and PGE 2 ) and on relative retention volume of the authentic standard 6,15-diketo-PGF 1a .
Results
Incubation Conditions
Adult human venous endothelial cells require a complex culture medium for growth. However, confluent monolayers of these cells can be maintained for at least 24 hours in serum-free media such as DMEM or Eagle's minimum essential medium (MEM). When LDL was incubated in either media without cells, no significant oxidation of LDL was observed (Table 1) . However, in the presence of cells, the use of MEM induced several-fold more LDL oxidation than the use of DMEM over a 24-hour period. An increase of BHT concentration from 1.7 /iM (average concentration after medium reconstitution) to 20 jaM in DMEM did not significantly protect LDL against oxidation.
Since EDTA (0.01 to 0.05 mM) was present in the LDL preparations used for tissue culture, the extent of EDTA toxicity was assessed by specific 111-indium release. When HSVEC were incubated in DMEM containing 1 mM EDTA, a significant specific release of 111 ln was observed, indicating cytotoxicity (Table 2) . When the cells were incubated with 0.1 mM EDTA, a concentration at least twice the concentration used during LDL incubation experiments, little toxicity was seen.
Confluent HSVEC can be maintained with control LDL in serum-free medium for at least 24 hours ( Figure 1) ; under those conditions the monolayers displayed a cobblestone phenotype characteristic of quiescent endothelial cells. In contrast, when the monolayers were incubated with Ox-LDL, the cells displayed an "activated" phenotype; the presence of debris in the medium was an indication of cell injury.
Prostacyclin Production
Ox-LDL, compared to control LDL, caused a marked increase in 6-keto-PGF 1o release from HSVEC. The increase in PGF 1o , measured by RIA of the medium, was concentration-dependent ( Figure 2 ). Ox-LDL induced a rapid rise in 6-keto-PGF 1a concentrations in the media of HSVEC, followed by a decrease, and a subsequent increase after several hours of incubations (Figure 3 ). The degree of LDL oxidation clearly affected this response, and the addition of LPDS decreased this response ( Figure  3) . Indomethacin inhibited the production of 6-keto-PGF, 0 by HSVEC (Figure 4 ). Ox-LDL (500 /xg/ml, TBARS 2.9 nmol/mg) induced a response similar to the response induced by the calcium ionophore A23187 (Figure 4) .
The antiserum for 6-keto-PGF,,, cross-reacted with LDL and especially with Ox-LDL at a given degree of oxidation. This cross-reactivity was linearly related to the amount of Values are the means of triplicate incubations. Confluent human saphenous vein endothelial cells were metabolically labeled with 1 "ln-oxine and were incubated with Dulbecco's modified Eagle's medium containing various concentrations of EDTA. After 24 hours, EDTA cytotoxicity was assessed by measuring the specific release of ' " I n in the medium, as described in the Methods section. with PGE 2 antiserum was observed (data not shown). In this system, the same kind of prostanoid response was noted, with Ox-LDL inducing a sixfold higher level of PGE 2 in the media than did control LDL over a 20-hour incubation (579±29 pg/ml vs. 99±14 pg/ml). Because of the cross-reactivity with the antisera, and our interest in examining the entire spectrum of prostanoids produced by HSVEC in response to LDL, we also used RP-HPLC methodology for assessing the presence of these constituents in the media after metabolic labeling. PGI 2 is not produced uniformly by cells isolated from various vascular beds. 33 To our knowledge, there is no available data on the HPLC profile of the prostanoids produced by adult human saphenous vein endothelial cells. Thus, we stimulated HSVEC with the ionophore A23187 to compare the prostanoid response to that induced by Ox-LDL. Confluent monolayers of HSVEC produced PGF^ with some PGE 2 and little 6-keto-PGF la ( Figure 5 ). This prostanoid profile was identical to the profile reported by others in porcine aortic endothelial cells stimulated with A23187 after preincubation with 14 C-arachidonate-labeled LDL. 34 In contrast, when HSVEC were incubated with Ox-LDL for 14 hours, the monolayers produced mainly PGI 2 metabolites as shown by the presence of 6-keto-PGF 1a and another PGI 2 degradation product, which has a relative retention volume similar to the relative retention volume of 6,15-diketo-PGF 1a ( Figure 6 ). Using metabolic labeling and HPLC analysis, no PGI 2 metabolites were detected until after several hours of incubation. These data indicate that the initial release of this constituent detected by RIA was derived from a pool of unlabeled arachidonic acid, either intracellular or extra-100 200 LDL (ug/ml) Ox-LDL within a range of 3.5 to 105 /tg of LDL protein (Table 3) . Control or Ox-LDL, however, did not quench RIA detection of 6-keto-PGF, o (data not shown). The data indicate that parallel incubations of LDL without cells must be performed to correct for cross-reactivity.
In similar experiments with human monocytes, crossreactivity of Ox-LDL (100 /ig/ml, TBARS 10. In A, levels of LDL were 500 /ig/ml (TBARS for Ox-LDL: 2.9 nmol/ mg). In B, levels of Ox-LDL were 200 /ug/ml (TBARS 6.8 nmol/ mg), and 5% LPDS (1.25 mg protein/ml) was used. PGI 2 production was assessed by radioimmunoassay of 6-keto-PGF 1a in the medium, as described in the Methods section. The values are the means±SD of duplicate incubations with control LDL (A), Ox-LDL (•), Ox-LDL and LPDS (A).
cellular. Cellular pool phenomena in prostaglandin synthesis by endothelial cells have been noted by others.
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Discussion
In characterized adult HSVEC, concentration and timedependence experiments demonstrated that Ox-LDL versus control LDL increased PGI 2 synthesis (Figures 2 and  3 ). This observation was confirmed by using a cyclooxygenase antagonist, which inhibited production of PGI 2 ( Figure 4 ). Further demonstration of this effect was provided by HPLC analysis after metabolic labeling, which showed that PGI 2 was the major prostanoid synthesized in response to Ox-LDL, despite the ability of these cells to also produce PGF^ and PGE 2 when exposed to the ionophore A23187 (Figures 5 and 6 ). Although it was not possible to observe early cytopathological effects (within minutes) when the monolayers were incubated with Ox-LDL, cell morphology was drastically altered after several hours of incubation with Ox-LDL (Figure 1 ). These obser- Values are the means±SD of duplicate incubations. Control low density lipoprotein (LDL) and oxidized LDL (Ox-LDL) (TBARS 9.6 nmol/mg) in Dulbecco's modified Eagle's medium were analyzed for 6-keto-PGF la cross-reactivity by radioimmunoassay as described in the Methods Section. The linear increase of Ox-LDL cross-reactivity with LDL protein level had a correlation coefficient of 0.9989.
vations indicate a link between Ox-LDL cytotoxicity and late PGI 2 release, and suggest that early PGI 2 release may also be a manifestation of Ox-LDL-mediated cytotoxicity.
A number of investigators have examined the effects of LDL on PGI 2 production by vascular tissue. 36 - 39 Beitz and Forster 36 have reported that LDL decreases PGI 2 production in microsomal fractions of pig aorta. Szczeklik and Gryglewski 37 -38 have noted that Ox-LDL decreases PGI 2 production in rat aorta slices as compared to control LDL. In contrast to these data, Spector et al. 39 have reported that LDL stimulates PGI 2 production by bovine aortic and human umbilical vein endothelial cells. In these latter studies, oxidation of LDL was not assessed. Our own experiments are not directly comparable with studies carried out in pig and rat aorta, since the preparations studied contained a variety of different cell types. 363738 However, in viable and well-characterized tissue cultures of endothelial cells, our results are consistent with those of Spector et al. We have extended these studies by examining the effects of Ox-LDL and control LDL.
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Precise control of the experimental conditions under which incubations of LDL with endothelial cells are performed is critical. Endothelial cells can modify LDL in a manner similar to copper-induced oxidation. 7 Certain media favor cell-induced LDL oxidation. Endothelial cells incubated in Ham's F10 medium (which contains 10 nM Cu 2+ ) induce rapid LDL oxidation, which can be prevented by BHT. 7 BHT has similar antioxidant properties in DMEM. In our cell preparation and in the presence of BHT, more LDL oxidation was seen with MEM than with DMEM (Table 1 ). Such a difference may be due to the higher levels of cysteine (a primary antioxidant) and tryptophan (an oxygen radical quencher) in DMEM than in MEM (2-and 1.6-fold, respectively). The presence of EDTA in the medium has also been reported to inhibit LDL oxidation by endothelial cells, probably because of its high affinity for Fe 2+ , Cu 2+ , and Zn 2+ . 7 However, too much EDTA will cause the chelator to complex significantly with Ca 2+ and Mg 2+ (which have a lower affinity constant than transition metals). 7 Using specific release of 111-indium as an index of cytolysis, we have shown that up to 100 /iM of EDTA can be tolerated by confluent HSVEC in DMEM over a 24-hour period (Table 2 ). In our experiments, the level of EDTA was always 100-fold higher than the level of Cu 2+ , but it never exceeded 100 /AM. Such concentrations of EDTA (0.01 to 0.05 mM) with BHT in the media are not toxic but still prevent oxidation of LDL by endothelial cells. HEPES was excluded from the final serum-free media since this buffer has been reported to stimulate endothelial cells to produce reactive oxygen metabolites. 40 The use of chloramphenicol during all steps of LDL purification protects against contamination with gram-negative bacterial endotoxins, which are known to induce PGI 2 production in endothelial cells. 41 During LDL preparation, NaN 3
was not used because this common bactericidal agent has been reported to promote LDL oxidation and subsequent apo B-100 degradation. 42 Ox-LDL can seriously affect radioimmunoassay of prostaglandins (Table 3) . There are several possible explanations for this effect. One possibility is that Ox-LDL crossreacts with the ligand-binding region of the pre-precipitated IgG and thus decreases the extent of competition between radiolabeled and unlabeled prostaglandins. A net decrease of recovered radioactivity would result in an increase of the calculated amount of prostaglandin. Another possibility is that Ox-LDL binds prostaglandins; this phenomenon is, however, unlikely since Ox-LDL does not quench RIA detection of 6-keto-PGF 1o (data not shown). To our knowledge, such cross-reactivity, which can be considerable at elevated levels of highly oxidized LDL, has not been previously reported. Thus, particular care needs to be taken when analyzing prostaglandins by RIA in media containing significant amounts of Ox-LDL.
The rapid initial increase of 6-keto-PGF la in the medium followed by a longer period of disappearance (Figure 3) suggests that the epitope becomes shielded from the antiserum. A priori, such a phenomenon could be due to binding of 6-keto-PGF 1a to the cells or to the culture dishes. Also, the prostanoid could bind to a cellular factor released in the medium. Since we did not find any evidence of 6-keto-PGF la binding to the cells or to the culture dishes (data not shown), it is possible that a binding factor is released from the cells and sequesters 6-keto-PGF 1o from the antiserum. Binding of PGI 2 to albumin and a Cohn fraction VI glycoprotein has been reported. 4344 Such findings raise the possibility that an endothelium-derived factor binds early metabolites of PGI 2 , perhaps to allow specific targeting to tissues equipped for further catabolism of these compounds. It is also possible that metabolizing enzymes are actively released and induce a modification of the epitope recognized by our antiserum. A third possibility is the leaking of metabolizing enzymes; this could occur at late stages of Ox-LDL cytotoxicity as indicated by the presence, after 14 hours of incubation, of 6,15-diketo-PGF 1a , a product of the cytoplasmic enzyme 15-hydroxy-prostaglandin dehydrogenase found in bovine arteries and veins. 45 Another explanation is that, as Ox-LDL is metabolized by the cells and disappears from the medium, the correction used for the RIA would then no longer be applicable and thus would reduce artefactually the final value of 6-keto-PGF 1o . Such a phenomenon is unlikely, because we estimate that less than 1 % of Ox-LDL (100 /xg/ml) is metabolized by HSVEC over 24 hours (calculations based on reported data about MDA-and acetylated-LDL catabolism by endothelial cells 4647 ).
The mechanisms by which Ox-LDL stimulates PGI 2 production in HSVEC are not clear. Endothelial cells express the LDL receptor and the scavenger receptor, which recognizes a more negatively charged apo B.
464748
Ox-LDL is recognized exclusively by the scavenger receptor, and it has been shown that this receptor allows endothelial cells to catabolize twice as much MDA-or acetylated-LDL than the amount of LDL that can be catabolized via the LDL receptor. 4647 These observations indicate that the presence of Ox-LDL may increase delivery of the lipoprotein components to the cell; such components (either common to control and Ox-LDL or specific to Ox-LDL) could trigger PGI 2 release. Furthermore, a phospholipase A 2 activity has been associated with Ox-LDL; 49 thus an increase in available arachidonic acid due to the lipoprotein could stimulate the cyclooxygenase pathway. 3450 The preferential use of arachidonic acid brought into the cells by the lipoprotein over endogenous arachidonate may be the reason for the late appearance of radiolabeled PGI 2 after metabolic labeling of the monolayer ( Figure 6 ). Also, lipid peroxides are known to stimulate or inhibit prostaglandin synthesis; 5152 such compounds could be brought into the cells or formed from membranes by reactive oxygen metabolites associated with Ox-LDL. The biphasic response shown in Figure 3 could be due, in part, to an activation followed by an inhibition and another activation induced by the sequential apparition of lipid peroxides.
The in vivo significance of our observation that oxidized LDL stimulates PGI 2 release by HSVEC remains elusive, for one must first demonstrate the in vivo significance of Ox-LDL. Smith and Staples 53 have shown that the relative distributions of LDL and proteins in plasma and intima are disparate: in normal aortic intima, these authors found a level of LDL twice the plasma level and a level of albumin a quarter of the plasma level. Serum inhibits oxidation and Ox-LDL-mediated injury, 1254 as well as PGI 2 stimulation in HSVEC (Figure 3) . One can speculate that LDL in the intimal space is much more susceptible to oxidation because of the lack of serum antioxidants and the ability of endothelial cells to oxidize LDL. High plasma levels of LDL, presumably resulting in a larger LDL infiltration into the intima, would exacerbate this effect. The intimal presence of Ox-LDL is suggested by several lines of evidence. LDL isolated from human aorta is more electronegative than plasma LDL, 55 a feature of oxidized LDL.
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Moreover, LDL isolated from human atherosclerotic lesions is degraded and induces cholesterol esterification in macrophages; 5657 both features are shared with Ox-LDL.
101112 ' 42 Therefore, once Ox-LDL is present in the intima, it may trap macrophages, thereby inducing foam cell formation and thus initiating and amplifying the injury events of atherosclerosis. 91058 Remarkably, PGI 2 can antagonize these events by inhibiting leukocyte adhesion and cholesterol accumulation in aortic smooth muscle cells.
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These observations, interpreted with the injury hypothesis for the pathogenesis of atherosclerosis, 56 suggest that oxidized LDL-induced production of PGI 2 by endothelial cells could be an in vivo mechanism of defense against the injury inflicted by modified lipoprotein.
